Allicin stimulates lymphocytes and elicits an antitumor effect: A possible role of p21ras

International Immunology

Volumn 16, Issue 2, 2004, Pages 275-281

  Patya, Miriam ^a   Zahalka, Muayad A ^a   Vanichkin, Alexey ^a   Rabinkov, Aharon ^b   Miron, Talia ^b   Mirelman, David ^b   Wilchek, Meir ^b   Lander, Harry M ^c   Novogrodsky, Abraham ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer immunotherapy; Extracellular signal regulated kinase; Free radical; p21ras

Indexed keywords

ALLICIN; CYSTEINE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P21; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL MEDIATED CYTOTOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MELANOMA; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; STATISTICAL ANALYSIS; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; ANIMALS; ANTI-INFECTIVE AGENTS; CYTOTOXICITY, IMMUNOLOGIC; ENZYME ACTIVATION; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; ONCOGENE PROTEIN P21(RAS); OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; SULFINIC ACIDS; T-LYMPHOCYTES;

EID: 1042269473     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh038     Document Type: Article

References (46)

1. Augusti, K. T. and Mathew PT. 1974. Lipid lowering effect of allicin (diallyl disulphide-oxide) on long term feeding to normal rats. Experientia 30:468.
2. Eilat, S., Oestraicher, Y., Rabinkov, A., Ohad, D., Mirelman, D., Battler, A., Eldar, M. and Vered, Z. 1995. Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron. Artery Dis. 6:985.
3. Agarwal, K. C. 1996. Therapeutic actions of garlic constituents. Med. Res. Rev. 16:111.
4. Lawson, L. D., Ransom, D. K. and Hughes, B. G. 1992. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products. Thromb. Res. 65:141.
5. Chu, T. C., Ogidigben, M., Han, J. C. and Potter, D. E. 1993. Allicin induced hypotension in rabbit eyes. J. Ocul. Pharmacol. 9:201.
6. Colic, M. and Savic, M. 2000. Garlic extracts stimulate proliferation of rat lymphocyte in vitro increasing IL-2 and IL-4 production. Immunopharmacol. Immunotoxicol. 22:163.
7. Morioka, N., Sze, L. L., Morton, D. L. and Irie, R. F. 1993. Protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A. Cancer Immunol. Immunother. 37:316.
8. Feng, Z. H., Zhang, G. M., Hao, T. L., Zhou, B., Zhang, H. and Jiang, Z. Y. 1994. Effect of diallyl trisulfide on the activation of T cell and macrophage-mediated cytotoxicity. J. Tongi. Med. Univ. 14:142.
9. Hodge, G., Hodge, S. and Han, P. 2002. Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease. Cytometry 48:209.
10. Kyo, E., Uda, N., Kasuga, S. and Itakura, Y. 2001. Immunomodulatory effect of aged garlic extract. J. Nutr. 131:1075S.
11. Lamm, D. L. and Riggs, D. R. 2001. Enhanced immunocompetence by garlic: role in bladder cancer and other malignancies. J. Nutr. 131:1067S.
12. Fleischauer, A. T. and Arab. L. 2001. Garlic and cancer: a critical review of the epidemiologic literature. J. Nutr. 131:1032S.
13. Milner, J. A. 1996. Garlic: its anticarcinogenic and anti-tumorigenic properties. Nutr. Rev. 54:S82.
14. Dorant, E., van den Brant, P. A., Goldbohm, R. A. and Sturman F. 1996. Consumption of onions and a reduced risk of stomach carcinoma. Gastroenterology 110:12.
15. Sieger, C. P., Steffen, B., Robke, A. and Pentz, R. 1999. The effect of garlic preparations against human tumor cell proliferation. Phytomedicine 6:7.
16. Sundaram, S. G. and Milner, J. S. 1996. Diallyl disulfide inhibits the proliferation of human tumor cells in culture. Biochim. Biophys Acta 1315:15.
17. Pinto, J. T. and Rivlin, R. S. 2001. Antiproliferative effects of allium derivatives from garlic. J. Nutr. 131(3S):1058S.
18. Cavallito, C. J., Buck, J. S. and Suter, C. M. 1944. Allicin the antibacterial principle of Allium sativum. II Determination of the chemical structure. J. Am. Chem. Soc. 66:1952.
19. Ankri, S., Miron, T., Rabinov, A., Wilchek, M. and Mirelman, D. 1997. Allicin from garlic strongly inhibits cysteine proteinases and cytopathic effects of Entamoeba histolytica. Antimicrob. Agents Chemother. 41:2286.
20. Margolin, K. A. 2000. Interleukin-2 in the treatment of renal cancer. Semin. Oncol. 27:194.
21. Queirolo, P., Ponte, M., Gipponi, M., Cafiero, F., Peressini, A., Semino,C., Pietra, G., Lionetto, R., Vecchio, S., Ribizzi, I., Melioli, G. and Sertoli, M. R. 1999. Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. Ann. Surg. Oncol. 6:272.
22. Hank, J. A., Albertini, M., Wesly, O. H., Schiller, J. H., Borchert, A., Moor, K., Bechhofer, R., Storer, B., Gan, J, and Gambacorti, C. 1995. Clinical and immunological effects of treatment with murine anti-CD3 monoclonal antibody along with interleukin 2 in patients with cancer. Clin. Cancer Res. 1:481.
23. Glennie, M. J. and Johnson, P. W. 2000. Clinical trials of antibody therapy. Immunol. Today 21:403.
24. Tsuji, A., Wang, J., Stenzel, K. H. and Novogrodsky, A. 1993. Immune stimulatory and anti-tumour properties of haemin. Clin. Exp. Immunol. 93:308.
25. Kovjazin, R., Eldar, T., Patya, M., Vanichkin, A., Lander, H. M. and Novogrodsky, A. 2003. Ferrocene-induced lymphocyte activation and antitumor activity is mediated by redox-sensitive signaling. FASEB J. 17:467.
26. Rabinkov, A., Miron, T., Konstantinovski, L., Wilchek, M., Mirelman, D. and Weiner, L. 1998. The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim. Biophys Acta 1379:233.
27. Torok, J. B., Belagyi, J., Rietz, B. and Jacob, R. 1944. Effectiveness of garlic on the radical activity in radical generating systems. Arzneimittelforschung 44:608.
28. Prasad, K., Laxdal, V. A., Yu, M. and Raney, BL. 1996. Evaluation of hydroxyl radical-scavenging property of garlic. Mol. Cell. Biochem. 154:55.
29. ras upon T-cell activation. Nature 346:719.
30. ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes. J. Exp. Med. 178:1199.
31. ras proteins in normal human T lymphocytes. J. Immunol. 148:2417.
32. ras. Eur. J. Immunol. 25:1044.
33. Novogrodsky, A., Ravid, A., Rubin, A. L. and Stenzel, K. H. 1982. Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc. Natl Acad. Sci. USA 79:1171.
34. Novogrodsky, A., Suthanthiran, M. and Stenzel, K. H. 1989. Immune stimulatory properties of metalloporphyrins. J. Immunol. 143:3981.
35. Novogrodsky, A., Suthanthiran, M. and Stenzel, K. H. 1991. Ferromitogens: iron-containing compounds with lymphocyte-stimulatory properties. Cell. Immunol. 133:295.
36. Lander, H. M., Levine, D. M. and Novogrodsky, A. 1992. Stress stimuli-induced lymphocyte activation. Cell. Immunol. 145:146.
37. Lander, H. M. 1997. An essential role for free radicals and derived species in signal transduction. FASEB J. 11:118.
38. Lander, H. M., Ogiste, J. S., Teng, K. K. and Novogrodsky, A. 1995. p21ras as a common signaling target of reactive free radical and cellular redox stress. J. Biol. Chem. 270:21195.
39. ras interaction. J. Biol. Chem. 272:4323.
40. Mott, H. R., Carpenter, J. W. and Campbell, S. L. 1997. Structural and functional analysis of a mutant ras protein that is insensitive to nitric oxide activation. Biochemistry 36:3640.
41. Deora, A. A., Win, T., Vanhaesebroeck, B. and Lander, H. M. 1998. A redox-triggered ras-effector interaction. Recruitment of phosphatidylinositol 3′-kinase to Ras by redox stress. J. Biol. Chem. 273:29923.
42. Deora, A. A., Hajjar, D. P. and Lander, H. M. 2000. Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras. Biochemistry 39:9901.
43. Stoll, A. and Seebeck, E. 1951. Chemical investigation on allicin, the specific principle of garlic. Adv. Enzymol. 11:377.
44. Tchernychev, B., Rabikov, A., Miron, T. and Wilchek M. 2000. Natural antibodies against allinase in human serum and polyclonal antibodies elicited in rabbit, share the same immunogenic determinants. Immunol. Lett. 71:43.
45. Jansen, H., Muller, B. and Knobloch, K. 1987. Allicin characterization and its determination by HPLC. Planta Medica 53:559.
46. Marshall, C. J. 1996, Ras effectors. Curr. Opin. Cell Biol. 8:197.